Back to top

Novonesis price target lowered to DKK 552 from DKK 560 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Novonesis (NVZMY) to DKK 552 from DKK 560 and keeps an Overweight rating on the shares. Published...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novozymes A/S (NVZMY)